Doc, here is my question. This is basically the same technology they are using in the cancer drug, correct? So, the cancer drug has at least a 10 year survival, so wouldn't then the expectation be along the same line?

I know they are working on a completely different virus, but the underlying technology is the same, so from how they were framing the way they were discussing it on the call, it sounded like they were kind of looking for the same results or am I entirely reading it wrong.